RWA Chainalysis reports that gray market peptide suppliers are increasingly using Bitcoin and stablecoins for transactions. This shift highlights the growing role of cryptocurrencies in illicit or unregulated pharmaceutical markets.
Chainalysis reports that gray market peptide suppliers are increasingly using Bitcoin and stablecoins for transactions. This shift highlights the growing role of cryptocurrencies in illicit or unregulated pharmaceutical markets.